Psoriasis Area and Severity Index is the most widely used tool for the measurement of severity of psoriasis. PASI combines the assessment of the severity of lesions and the area affected into a single score in the range 0 to 72. From Wikipedia
Halting atopic dermatitis trials, Sun Pharma is collaborating with SPARC on new development plans following Vibozilimod’s failure to meet primary endpoints.
